Tardive Dyskinesia in the Aged

Duration of Treatment Relationships

Linda M. Toenniessen, Daniel Casey, Bentson McFarland

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Although tardive dyskinesia (TD) is recognized to result from neuroleptic drug exposure, data conflict about the importance of the quantity of that exposure in producing TD. The relationship between duration of neuroleptic treatment (one to 301 months) and TD was studied in 57 elderly psychiatric inpatients. Examinations for TD and parkinsonism were quantified on the Abnormal Involuntary Movement Scale (AIMS) and on a parkinsonism severity scale. Prevalence of presumed TD was 49% and of parkinsonism 51%. Prevalence of TD increased with longer treatment, but parkinsonism was independent of treatment duration. Linear multiple regression analysis showed that the AIMS score was correlated positively with treatment duration and negatively with parkinsonism. Logistic multiple regression analysis verified these relationships and was more successful at predicting TD. The length of neuroleptic treatment necessary to produce TD was calculated from the logistic model at 10.8 months (95% confidence interval, zero to 25.6 months). These analyses showed the greatest rise in risk of TD occurred within the first two years of drug therapy.

Original languageEnglish (US)
Pages (from-to)278-284
Number of pages7
JournalArchives of General Psychiatry
Volume42
Issue number3
DOIs
StatePublished - 1985

Fingerprint

Parkinsonian Disorders
Antipsychotic Agents
Therapeutics
Logistic Models
Regression Analysis
Tardive Dyskinesia
Psychiatry
Inpatients
Linear Models
Confidence Intervals
Drug Therapy
Multiple Regression
Involuntary
Drugs
Abnormal Involuntary Movement Scale

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Psychiatry and Mental health

Cite this

Tardive Dyskinesia in the Aged : Duration of Treatment Relationships. / Toenniessen, Linda M.; Casey, Daniel; McFarland, Bentson.

In: Archives of General Psychiatry, Vol. 42, No. 3, 1985, p. 278-284.

Research output: Contribution to journalArticle

Toenniessen, Linda M. ; Casey, Daniel ; McFarland, Bentson. / Tardive Dyskinesia in the Aged : Duration of Treatment Relationships. In: Archives of General Psychiatry. 1985 ; Vol. 42, No. 3. pp. 278-284.
@article{726673f17ce843e281449f1e630fa23c,
title = "Tardive Dyskinesia in the Aged: Duration of Treatment Relationships",
abstract = "Although tardive dyskinesia (TD) is recognized to result from neuroleptic drug exposure, data conflict about the importance of the quantity of that exposure in producing TD. The relationship between duration of neuroleptic treatment (one to 301 months) and TD was studied in 57 elderly psychiatric inpatients. Examinations for TD and parkinsonism were quantified on the Abnormal Involuntary Movement Scale (AIMS) and on a parkinsonism severity scale. Prevalence of presumed TD was 49{\%} and of parkinsonism 51{\%}. Prevalence of TD increased with longer treatment, but parkinsonism was independent of treatment duration. Linear multiple regression analysis showed that the AIMS score was correlated positively with treatment duration and negatively with parkinsonism. Logistic multiple regression analysis verified these relationships and was more successful at predicting TD. The length of neuroleptic treatment necessary to produce TD was calculated from the logistic model at 10.8 months (95{\%} confidence interval, zero to 25.6 months). These analyses showed the greatest rise in risk of TD occurred within the first two years of drug therapy.",
author = "Toenniessen, {Linda M.} and Daniel Casey and Bentson McFarland",
year = "1985",
doi = "10.1001/archpsyc.1985.01790260072009",
language = "English (US)",
volume = "42",
pages = "278--284",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Tardive Dyskinesia in the Aged

T2 - Duration of Treatment Relationships

AU - Toenniessen, Linda M.

AU - Casey, Daniel

AU - McFarland, Bentson

PY - 1985

Y1 - 1985

N2 - Although tardive dyskinesia (TD) is recognized to result from neuroleptic drug exposure, data conflict about the importance of the quantity of that exposure in producing TD. The relationship between duration of neuroleptic treatment (one to 301 months) and TD was studied in 57 elderly psychiatric inpatients. Examinations for TD and parkinsonism were quantified on the Abnormal Involuntary Movement Scale (AIMS) and on a parkinsonism severity scale. Prevalence of presumed TD was 49% and of parkinsonism 51%. Prevalence of TD increased with longer treatment, but parkinsonism was independent of treatment duration. Linear multiple regression analysis showed that the AIMS score was correlated positively with treatment duration and negatively with parkinsonism. Logistic multiple regression analysis verified these relationships and was more successful at predicting TD. The length of neuroleptic treatment necessary to produce TD was calculated from the logistic model at 10.8 months (95% confidence interval, zero to 25.6 months). These analyses showed the greatest rise in risk of TD occurred within the first two years of drug therapy.

AB - Although tardive dyskinesia (TD) is recognized to result from neuroleptic drug exposure, data conflict about the importance of the quantity of that exposure in producing TD. The relationship between duration of neuroleptic treatment (one to 301 months) and TD was studied in 57 elderly psychiatric inpatients. Examinations for TD and parkinsonism were quantified on the Abnormal Involuntary Movement Scale (AIMS) and on a parkinsonism severity scale. Prevalence of presumed TD was 49% and of parkinsonism 51%. Prevalence of TD increased with longer treatment, but parkinsonism was independent of treatment duration. Linear multiple regression analysis showed that the AIMS score was correlated positively with treatment duration and negatively with parkinsonism. Logistic multiple regression analysis verified these relationships and was more successful at predicting TD. The length of neuroleptic treatment necessary to produce TD was calculated from the logistic model at 10.8 months (95% confidence interval, zero to 25.6 months). These analyses showed the greatest rise in risk of TD occurred within the first two years of drug therapy.

UR - http://www.scopus.com/inward/record.url?scp=0021837391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021837391&partnerID=8YFLogxK

U2 - 10.1001/archpsyc.1985.01790260072009

DO - 10.1001/archpsyc.1985.01790260072009

M3 - Article

VL - 42

SP - 278

EP - 284

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 3

ER -